Stock comparison
Novartis AG is 316.9x more valuable than Harrow, Inc. by market capitalization ($309.21 B vs $975.86 M). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
NVS is larger
Novartis AG is 316.9x more valuable than Harrow, Inc. by market capitalization ($309.21 B vs $975.86 M).
Market value leader
NVS
Novartis AG is 316.9x more valuable than Harrow, Inc. by market capitalization ($309.21 B vs $975.86 M).
| Metric | HROW | NVS |
|---|---|---|
| Market cap | $975.86 M | $309.21 B |
| US-listed rank | #2548 | #38 |
| Revenue (latest FY) | $272.30M | - |
| Net income (latest FY) | -$5.14M | - |
| Net margin | -1.9% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 849 | 953 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Novartis AG is 316.9x more valuable than Harrow, Inc. by market capitalization ($309.21 B vs $975.86 M).
Full pages: Harrow, Inc. and Novartis AG, or browse the full rankings.